Bayer - Performance Snapshot

[Forum Admin]

Performance Snapshot:

Bayer AG

BAYN

Over Time

1-Year Growth
+4.78%
5-Year Change
-59.48%

Bayer Deep Dive

Bayer is one of the world’s oldest and most influential pharmaceutical and life science companies. Despite recent struggles, its innovation pipeline and restructuring efforts make it a stock to watch.

 New leadership — In 2023, Bayer appointed a new CEO focused on cutting costs, restructuring, and reviving shareholder confidence.
 
 Agrochemical momentum — Its crop science division remains a global leader.
 
 Patent power — Bayer’s pharmaceutical arm is doubling down on oncology and rare diseases.

 

Did You Know?

 Aspirin legacy — Bayer invented aspirin in 1899, and it’s still one of the most widely used drugs globally.
 
 Monsanto acquisition — In 2018, Bayer bought Monsanto for $63B, a deal that brought major growth potential… and major legal headaches.
 
 Dividend dilemma — In 2024, Bayer cut its dividend for the first time in over a decade, signaling a shift toward debt reduction and reinvestment.